I haven't seen anything to suggest that this is definitely off track. The peer review phase may take about 3 months*, which means that the results can be verified and peer-reviewed by March (which is still Q1 2018). The timeline only says that these results are likely to be published in the Q2 edition of a medical journal.
With the peer-reviewed clinicial trial data, the FDA shouldn't take more than 3 weeks* to process and hopefully approve a submission.
* I got these estimates from asking a friend who is doing his Masters after graduating in Medical Science. So I'm not claiming to know these timeframes for sure, but he probably knows a thing or two about the scientific process in medical research
- Forums
- ASX - By Stock
- NTI
- anticipated results
anticipated results, page-36
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NTI (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.0¢ |
Change
0.001(1.45%) |
Mkt cap ! $64.55M |
Open | High | Low | Value | Volume |
7.1¢ | 7.1¢ | 7.0¢ | $16.67K | 237.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 75250 | 6.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 23082 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 589299 | 0.070 |
1 | 36231 | 0.069 |
5 | 240000 | 0.068 |
2 | 255000 | 0.067 |
3 | 262000 | 0.066 |
Price($) | Vol. | No. |
---|---|---|
0.072 | 100000 | 1 |
0.074 | 40000 | 1 |
0.075 | 738582 | 2 |
0.076 | 90000 | 1 |
0.077 | 190000 | 3 |
Last trade - 14.13pm 28/11/2024 (20 minute delay) ? |
NTI (ASX) Chart |